Search results
How psychedelic-assisted therapies can be more effective
Popular Science via Yahoo News· 3 hours agoThe clinician provides hours or preparation and also guides the patient through the experience and...
Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s...
Fortune via AOL· 2 hours agoPrice Target: $58 12-month Appreciation Potential: 46% LifeStance Health Group LifeStance Health...
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Zacks via Yahoo Finance· 9 hours agoVertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem...
Intra-Cellular Therapies (NASDAQ:ITCI) Given New $96.00 Price Target at Mizuho
ETF DAILY NEWS· 18 hours agoThe Goldman Sachs Group upped their target price on shares of Intra-Cellular Therapies from $67.00 to $77.00 and gave the stock a neutral rating in a research note on Wednesday ...
America’s health system is still in crisis after its biggest cyberattack ever—but the ‘catastrophe’...
Fortune via Yahoo Finance· 5 hours agoIn early March, Joe Martin, the owner of Function Better, a physical therapy clinic in Yorkville,...
Jon Bon Jovi's wife told him his voice 'wasn't great' before vocal cord surgery
Today· 3 hours agoA new docuseries about one of the most popular rock bands of all time will feature one of the most...
Cellares, BMS announce $380M cell therapy manufacturing agreement
NJBIZ· 10 hours agoBristol Myers Squibb and Cellares announced Monday a worldwide capacity reservation and supply...
Bristol Myers taps startup to boost cell therapy production
BioPharma Dive via Yahoo Finance· 1 day agoIn a statement, Lynelle Hoch, head of the pharmaceutical company’s cell therapy unit, said the...
Celine Dion details life with stiff-person syndrome ahead of new documentary. Here's what it's like...
Yahoo Life· 7 hours agoI stay at home, listen to my songs, stand in front of my mirror and sing to myself." The 56-year-old...
8,152 Shares in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Bought by Calamos Advisors LLC
ETF DAILY NEWS· 15 hours agoCalamos Advisors LLC purchased a new position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities ...